New target for fighting Alzheimer's: study

January 26, 2010

French researchers said Tuesday they had found a promising new target in the fight against Alzheimer's, the debilitating brain disease that causes irreversible memory loss and dementia.

In laboratory experiments, a team led by Etienne-Emile Beaulieu of the French National Institute of Health and Medical Research (INSERM) uncovered what could prove a critically important interaction between two types of proteins.

The telltale symptoms of Alzheimer's and other have been linked to an overabundance in the brain of the tau protein.

Beaulieu and colleagues discovered that another protein known as FKBP52, which also helps regulate immune responses, may slow or prevent that damaging accumulation.

"It's an 'anti-tau' weapon located within the cells," Beaulieu said at a press conference in Paris.

"We want to boost the efficiency of this weapon and find pharmaceutical ammunition -- new drugs -- to accelerate its action so that it can destroy unwanted tau," he told journalists.

The study was published this week in the US .

Developing such a drug may take a long time, he said, "but in two or three years we should be able to find a way to at least make an early diagnosis."

Certain biochemical markers of the illness probably appear 10 or 15 years before clinical symptoms, he added.

Further experiments based on the results reported Tuesday will begin soon with geriatrics patients at the Charles Foix d'Ivry Hospital outside of Paris, he announced.

Beaulieu is best known as the inventor of the RU-486 "abortion pill", first developed in 1980.

Other researchers said the link between the two types of proteins was important, but remained skeptical of an early breakthrough for treatment.

"Everything reported here was done in the laboratory," said Philippe Amouyel, director of France's National Scientific Foundation for .

"This lead must be followed up, but for the moment there is no direct link to Alzheimer's, and no demonstration that it works on patients," he told AFP.

There are hundreds of proteins that interact with tau, and further research is needed to see how the interaction between FKBP52 and tau fit into the larger puzzle of the disease, he added.

Alzheimer's has also been associated with amyloid beta proteins that accumulate around neurons in the , forming plaques.

An estimated 37 million people worldwide, including 5.3 million in the United States, live with dementia, with Alzheimer's disease causing the majority of cases, according to the World Health Organization.

As populations age, this figure is projected to increase rapidly over the next 20 years.

Related Stories

Recommended for you

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.